sgrna vector Search Results


97
Addgene inc cas9
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm27219625-186-4-13?v=Addgene+inc
Average 97 stars, based on 1 article reviews
cas9 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

95
Addgene inc puc57 sgrna expression vector
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Puc57 Sgrna Expression Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm25271839-60-83-86?v=Addgene+inc
Average 95 stars, based on 1 article reviews
puc57 sgrna expression vector - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Addgene inc u6 sgrna cloning vector
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
U6 Sgrna Cloning Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pmc11113635-122-0-23?v=Addgene+inc
Average 93 stars, based on 1 article reviews
u6 sgrna cloning vector - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Addgene inc abe7 10 max vrqr c
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Abe7 10 Max Vrqr C, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pmc10088465-458-25-30?v=Addgene+inc
Average 91 stars, based on 1 article reviews
abe7 10 max vrqr c - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

92
Addgene inc plasmids puc57 sa sgrna
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Plasmids Puc57 Sa Sgrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pmc06002399-195-0-16?v=Addgene+inc
Average 92 stars, based on 1 article reviews
plasmids puc57 sa sgrna - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

92
Addgene inc sgrna vector
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Sgrna Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pmc10698695-207-2-13?v=Addgene+inc
Average 92 stars, based on 1 article reviews
sgrna vector - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
Lonza px458/px459 plasmids
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Px458/Px459 Plasmids, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/bio_rxiv__2021__07__22__453348-306-1-11?v=Lonza
Average 90 stars, based on 1 article reviews
px458/px459 plasmids - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BestGene Inc vectors for sgrna expression
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Vectors For Sgrna Expression, supplied by BestGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm30601807-362-2-14?v=BestGene+Inc
Average 90 stars, based on 1 article reviews
vectors for sgrna expression - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenScript corporation sgrna expression vector
Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by <t>Cas9</t> protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show <t>Cas9</t> <t>protein</t> or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.
Sgrna Expression Vector, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm32738650-55-38-59?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
sgrna expression vector - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenScript corporation sgrna vectors containing oryza sativa u6 promoter
Strategy for targeted mutagenesis of sugarcane MgCh and confirmation of In-vitro cleavage activity of sgRNAs. (A) Schematic representation of sugarcane MgCh locus and sgRNAs' target sites, sgRNA1 targeting nts 731–750 and sgRNA2 targeting nts 1223–1242. Mutations at <t>sgRNA</t> target site 1 would disrupt the Nco I restriction recognition site. Exons are indicated with green boxes, and introns with yellow boxes. (B) In vitro cleavage assay to validate sgRNA activity, the (810 nts) MgCh PCR amplicon is digested by ribonucleoprotein complex (RNP) of Cas9 and either sgRNA1 or sgRNA2 into ~581 and 229 nts or 701 and 109 nts, respectively. (C) Map of sugarcane gene editing plasmid (pMGE); Two sgRNAs are monoscistronically expressed <t>under</t> <t>Oryza</t> sativa U6 promoter, npt II is under transcriptional control of cauliflower mosaic virus (CaMV) 35S promoter and CaMV terminator, Cas9 is under transcriptional control of CaMV 35S promoter and Sorghum bicolor HSP18 terminator. Protospacer adjacent motifs (PAMs) are indicated in red font.
Sgrna Vectors Containing Oryza Sativa U6 Promoter, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pmc08525377-75-0-16?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
sgrna vectors containing oryza sativa u6 promoter - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Audentes Therapeutics sgrna raav9 vectors
Strategy for targeted mutagenesis of sugarcane MgCh and confirmation of In-vitro cleavage activity of sgRNAs. (A) Schematic representation of sugarcane MgCh locus and sgRNAs' target sites, sgRNA1 targeting nts 731–750 and sgRNA2 targeting nts 1223–1242. Mutations at <t>sgRNA</t> target site 1 would disrupt the Nco I restriction recognition site. Exons are indicated with green boxes, and introns with yellow boxes. (B) In vitro cleavage assay to validate sgRNA activity, the (810 nts) MgCh PCR amplicon is digested by ribonucleoprotein complex (RNP) of Cas9 and either sgRNA1 or sgRNA2 into ~581 and 229 nts or 701 and 109 nts, respectively. (C) Map of sugarcane gene editing plasmid (pMGE); Two sgRNAs are monoscistronically expressed <t>under</t> <t>Oryza</t> sativa U6 promoter, npt II is under transcriptional control of cauliflower mosaic virus (CaMV) 35S promoter and CaMV terminator, Cas9 is under transcriptional control of CaMV 35S promoter and Sorghum bicolor HSP18 terminator. Protospacer adjacent motifs (PAMs) are indicated in red font.
Sgrna Raav9 Vectors, supplied by Audentes Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm36634841-157-37-1?v=Audentes+Therapeutics
Average 90 stars, based on 1 article reviews
sgrna raav9 vectors - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Broad Institute Inc lentiviral sgrna expression vectors pxpr_brd043
Strategy for targeted mutagenesis of sugarcane MgCh and confirmation of In-vitro cleavage activity of sgRNAs. (A) Schematic representation of sugarcane MgCh locus and sgRNAs' target sites, sgRNA1 targeting nts 731–750 and sgRNA2 targeting nts 1223–1242. Mutations at <t>sgRNA</t> target site 1 would disrupt the Nco I restriction recognition site. Exons are indicated with green boxes, and introns with yellow boxes. (B) In vitro cleavage assay to validate sgRNA activity, the (810 nts) MgCh PCR amplicon is digested by ribonucleoprotein complex (RNP) of Cas9 and either sgRNA1 or sgRNA2 into ~581 and 229 nts or 701 and 109 nts, respectively. (C) Map of sugarcane gene editing plasmid (pMGE); Two sgRNAs are monoscistronically expressed <t>under</t> <t>Oryza</t> sativa U6 promoter, npt II is under transcriptional control of cauliflower mosaic virus (CaMV) 35S promoter and CaMV terminator, Cas9 is under transcriptional control of CaMV 35S promoter and Sorghum bicolor HSP18 terminator. Protospacer adjacent motifs (PAMs) are indicated in red font.
Lentiviral Sgrna Expression Vectors Pxpr Brd043, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sgrna+vector/pm35405016-439-27-42?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
lentiviral sgrna expression vectors pxpr_brd043 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by Cas9 protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show Cas9 protein or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Article Title: Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.

doi: 10.1111/gtc.12379

Figure Lengend Snippet: Figure 4 Genotyping of founders with different phenotypes with RFLP analyses. (A) A schematic of restriction enzyme-RFLP (RE-RFLP) and RNA-guided engineered nuclease-RFLP (RGEN-RFLP) analysis. (B) Estimation of somatic mutation rates of the target alleles in each phenotype. PCR products of tyr and ltk were cleaved by Cas9 protein with sgRNAs in vitro. PCR prod- ucts of slc45a2 were cleaved by BfaI. Cleaved fragments were analyzed by electrophoresis (MultiNA system; Shimadzu). Upper and lower images show Cas9 protein or BfaI (+) and () gel images converted from electropherograms. PCR products of target regions are shown by black arrowheads. Colored arrowheads indicate cleaved products by Cas9 or BfaI. Some extra bands were observed and thought to be large deletions and insertions. The mutation rates were calculated from the molarity of the uncleaved bands (black arrowheads and other extra bands) and the larger cleaved fragments (blue arrowheads). Wt, wild type; W, weak phe- notype; M, moderate phenotype; S, severe phenotype; PS, severe phenotype by Cas9 protein injection; H, half phenotype; F, full phenotype. Full scan images of RFLP analyses are shown in Figs S5–S8 in Supporting Information.

Article Snippet: Preparation and injection of Cas9 and sgRNA Humanized codon hspCas9 cDNA from pX330 (Addgene, #42230; Cong et al. 2013) containing two NLSs was subcloned into a modified pCS2+ vector (pCS2+-T7/hspCas9; Fig. S12 in Supporting Information).

Techniques: Mutagenesis, In Vitro, Electrophoresis, Injection

Figure 7 Example of target gene analysis according to our workflow. We designed an sgRNA targeting activin receptor-like kinase 2 (alk2). (A) Representative phenotypes produced by Cas9 mRNA and sgRNA (upper panel). Most phenotypes exhibited a partial loss of ventral fin tissue accompanied by the hypertrophic anus. Normal means no alteration in the ventral fin or anus. The total numbers of individuals are shown at the top of each graph. In vitro fertilization (IVF) indicates control embryos without injection. Frequencies of alk2-disrupted phenotypes from three independent experiments are shown in under panel. (B) RGEN-RFLP analy- sis of somatic mutation rates. (C) Sanger DNA sequencing of somatic mutation alleles from five phenotypes. In total, 107 clones were sequenced. (D) Off-target analysis using heteroduplex mobility assay (HMA). Wt, wild type; P, phenotype.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Article Title: Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.

doi: 10.1111/gtc.12379

Figure Lengend Snippet: Figure 7 Example of target gene analysis according to our workflow. We designed an sgRNA targeting activin receptor-like kinase 2 (alk2). (A) Representative phenotypes produced by Cas9 mRNA and sgRNA (upper panel). Most phenotypes exhibited a partial loss of ventral fin tissue accompanied by the hypertrophic anus. Normal means no alteration in the ventral fin or anus. The total numbers of individuals are shown at the top of each graph. In vitro fertilization (IVF) indicates control embryos without injection. Frequencies of alk2-disrupted phenotypes from three independent experiments are shown in under panel. (B) RGEN-RFLP analy- sis of somatic mutation rates. (C) Sanger DNA sequencing of somatic mutation alleles from five phenotypes. In total, 107 clones were sequenced. (D) Off-target analysis using heteroduplex mobility assay (HMA). Wt, wild type; P, phenotype.

Article Snippet: Preparation and injection of Cas9 and sgRNA Humanized codon hspCas9 cDNA from pX330 (Addgene, #42230; Cong et al. 2013) containing two NLSs was subcloned into a modified pCS2+ vector (pCS2+-T7/hspCas9; Fig. S12 in Supporting Information).

Techniques: Produced, In Vitro, Control, Injection, Mutagenesis, DNA Sequencing, Clone Assay

Strategy for targeted mutagenesis of sugarcane MgCh and confirmation of In-vitro cleavage activity of sgRNAs. (A) Schematic representation of sugarcane MgCh locus and sgRNAs' target sites, sgRNA1 targeting nts 731–750 and sgRNA2 targeting nts 1223–1242. Mutations at sgRNA target site 1 would disrupt the Nco I restriction recognition site. Exons are indicated with green boxes, and introns with yellow boxes. (B) In vitro cleavage assay to validate sgRNA activity, the (810 nts) MgCh PCR amplicon is digested by ribonucleoprotein complex (RNP) of Cas9 and either sgRNA1 or sgRNA2 into ~581 and 229 nts or 701 and 109 nts, respectively. (C) Map of sugarcane gene editing plasmid (pMGE); Two sgRNAs are monoscistronically expressed under Oryza sativa U6 promoter, npt II is under transcriptional control of cauliflower mosaic virus (CaMV) 35S promoter and CaMV terminator, Cas9 is under transcriptional control of CaMV 35S promoter and Sorghum bicolor HSP18 terminator. Protospacer adjacent motifs (PAMs) are indicated in red font.

Journal: Frontiers in Genome Editing

Article Title: Multiallelic, Targeted Mutagenesis of Magnesium Chelatase With CRISPR/Cas9 Provides a Rapidly Scorable Phenotype in Highly Polyploid Sugarcane

doi: 10.3389/fgeed.2021.654996

Figure Lengend Snippet: Strategy for targeted mutagenesis of sugarcane MgCh and confirmation of In-vitro cleavage activity of sgRNAs. (A) Schematic representation of sugarcane MgCh locus and sgRNAs' target sites, sgRNA1 targeting nts 731–750 and sgRNA2 targeting nts 1223–1242. Mutations at sgRNA target site 1 would disrupt the Nco I restriction recognition site. Exons are indicated with green boxes, and introns with yellow boxes. (B) In vitro cleavage assay to validate sgRNA activity, the (810 nts) MgCh PCR amplicon is digested by ribonucleoprotein complex (RNP) of Cas9 and either sgRNA1 or sgRNA2 into ~581 and 229 nts or 701 and 109 nts, respectively. (C) Map of sugarcane gene editing plasmid (pMGE); Two sgRNAs are monoscistronically expressed under Oryza sativa U6 promoter, npt II is under transcriptional control of cauliflower mosaic virus (CaMV) 35S promoter and CaMV terminator, Cas9 is under transcriptional control of CaMV 35S promoter and Sorghum bicolor HSP18 terminator. Protospacer adjacent motifs (PAMs) are indicated in red font.

Article Snippet: sgRNA vectors containing Oryza sativa U6 promoter were designed and custom synthesized in the pUC57 backbone (Genscript, NJ, USA) to generate pUCMg12.

Techniques: Mutagenesis, In Vitro, Activity Assay, Cleavage Assay, Amplification, Plasmid Preparation, Control, Virus